Health Catalyst General Counsel Landry Benjamin forfeited 13,167 shares at $1.70 per share on September 1, 2026. The transaction leaves Benjamin with 351,372 shares, giving investors a precise view of his reported remaining Health Catalyst holding after the forfeiture for ownership tracking.
Key Highlights
- Landry Benjamin was identified as Health Catalyst’s General Counsel in the transaction.
- The share forfeiture was dated September 1, 2026.
- Benjamin’s reported post-transaction ownership was 351,372 shares.
An official filing states that Landry Benjamin forfeited 13,167 shares at $1.70 per share. Benjamin owned 351,372 shares following the transaction.
Health Catalyst (NASDAQ: HCAT) Share Forfeiture Details
The filing states that Landry Benjamin forfeited the shares on September 1, 2026, in his capacity as General Counsel of Health Catalyst (NASDAQ: HCAT). The forfeiture covered 13,167 shares and was reported at $1.70 per share. The filing reports the number of shares forfeited and Benjamin’s ownership following the transaction.
FAQs
Q: How many Health Catalyst shares did Landry Benjamin forfeit?
A: The filing states that Landry Benjamin forfeited 13,167 Health Catalyst shares. It reports a transaction price of $1.70 per share for the forfeiture.
Q: What was the impact on Landry Benjamin’s HCAT ownership?
A: Following the transaction, Benjamin owned 351,372 Health Catalyst shares. The filing identified him as the company’s General Counsel in the regulatory Form 4 filing.
Q: When did the Health Catalyst share forfeiture occur?
A: The filing reports that the forfeiture occurred on September 1, 2026. It involved 13,167 shares at a stated price of $1.70 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.